Top PDF Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer
Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer
... increase in the incidence of lung cancer in women in re- cent years, it has brought broad concerns with its unique clinical and epidemiological characteristics and beter ...
6
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
... determination of plasma mSHOX2 DNA ap- pears to be useful for the monitoring of a treatment response for advanced stage lung cancer ...rate of cell-free DNA is rather high ...
10
An Overview: Treatment of Lung Cancer on Researcher Point of View
... inhibitor of gefitinib this inhibitor for signaling to increase grows. The patients who are affected by gefitinib are exposed to screening for identification of lung cancer ...
7
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
... Interstitial lung disease (ILD) is considered as a major safety concern for ...incidence of ILD among gefitinib-treated patients was ...rate of ILD was reported to be 0.12–0.5%.[19–21] ILD was ...
11
The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
... consecutive patients with advanced NSCLC treated in Department of Chemotherapy, UMHAT- ...analyzed. Of those, 27 patients /34, 6%/ had low hemoglobin /HB/ level ...
4
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
... vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological ...interacting with other cells of the tumor microenvironment, modulate tumor progression, ...
13
Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.
... heterogeneity of EGFR, we microdissected bulk tumor tissue to obtain 28–34 foci per tumor and analyzed each focus for EGFR mutation status using qualitative and semi-quantitative ...Most of the ...
7
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
... regression analysis, by assigning a weight equal to the sample size to each ...strength of associations was defined a priori using the commonly accepted criteria for the coefficient of determina- ...
8
Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
... among patients with completely resected NSCLC but that arterial invasion did not ...However, in most of the studies, arterial and venous invasion has not been separately studied pathologically ...
8
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
... revealed patients with higher MBR had better PFS ...Although patients with high MBR had almost twice longer OS than those with low MBR ...noted in log-rank test. (p = 0.074) It ...
13
Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
... Subgroup analysis is a method for exploring the sources of heterogeneity and for increasing the reliability of an ...prognosis of NSCLC [39]. While the patients in the included ...
13
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... is of great importance in cancer initiation and ...risk factors for many cancer types, including lung can- ...impacts of TERT variants on cancer progression and ...
13
The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.
... role in the survival of cancer cells in breast, prostate, ovary, and brain tissue ...survival of NSCLC cell [29]. Recently, a clinical study of p-AKT expression in ...
6
THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
... Lung cancer remains the most common cause of can- cer death worldwide for both men and ...85% of all lung cancer cases ...improvements of diagnostic technologies, ...
5
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... inflammation, cancer can induce local or systemic inflammation, which is mediated by activation of transcription factors and production of major inflammatory cyto- kines ...hand, ...
14
Rev. bras. epidemiol. vol.17 número4
... on Non-Small Cell Lung Cancer (NSCLC) are scarce with regard to the private health care in ...aim of this study was to describe the characteristics, treatments ...
14
Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN
... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...objective ...
102
Sao Paulo Med. J. vol.134 número5
... compared non-platinum single-agent therapy versus non-platinum combination therapy, or non-platinum therapy versus platinum combination therapy in pa- tients over 70 years of age ...
2
PDF EN Jornal Brasileiro de Pneumologia 3 1 english
... number of patients with occult metastases in the regional lymph nodes is ...use of more than one technique can increase the detection of positive lymph nodes ...importance ...
2
Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
... included in the final analysis, the average sample size was small ...curves in these articles indirectly, which could be another potential source of ...methods of examining bFGF ...
14